AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MeVis Medical Solutions AG

Declaration of Voting Results & Voting Rights Announcements Apr 23, 2015

287_dva_2015-04-23_2b436f5d-04ba-43de-829f-c81b3ee0fdcd.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

News Details

Voting Rights Announcements | 23 April 2015 18:01

MeVis Medical Solutions AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

MeVis Medical Solutions AG

23.04.2015 18:01

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


On April 23, 2015, Ms Petra Neureither, Germany has informed us according
to Article 21, Section 1 of the WpHG that via shares her Voting Rights on
MeVis Medical Solutions AG, Bremen, Germany, have fallen below the 5% and
3% threshold of the Voting Rights on April 21, 2015 and on that day
amounted to 0% (this corresponds to 0 Voting Rights).
0% of Voting Rights (this corresponds to 0 Voting Rights) are attributed to
Ms Neureither in accordance with Article 22, Section 1, Sentence 1, No. 1
of the WpHG (German Securities Trading Act). Attributed Voting Rights are
held by the following companies under her control, whose share of the
Voting Rights in MeVis Medical Solutions AG amounts to 3 percent or more:
PEN GmbH.

23.04.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Internet: http://www.mevis.de

End of Announcement DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.